Use of Transient Evoked Otoacoustic Emissions to Detect and Monitor Cochlear Damage Caused by Platinum-Containing Drugs

References

• Anderson, SD. Some ECMR properties in relation to other signals from the auditory periphery Hear Res 1980 2 273–96.
   PubMed Web of Science ®Google Scholar
• Anderson, SD, Kemp, DT. The evoked cochlear mechanical response in laboratory primates A preliminary report. Arch Otorhinolaryngol 1979 224 47–54.
   PubMed Web of Science ®Google Scholar
• Association of the British Pharmaceutical Industry Data sheet compendium 1994–95 Datapharm Publications Ltd London 1994.
   Google Scholar
• Black, FO, Myers, EN, Schramm, VL, Johnson, J, Sigler, B, Thearle, PB, Burns, DS. Cisplatinum vestibular ototoxicity: Preliminary report Laryngoscope 1982 92 1363–8.
   PubMed Web of Science ®Google Scholar
• Blakley, BW, Gupta, AK, Myers, SF, Schwan, S. Risk factors for ototoxicity due to cisplatin Arch Otolaryngol Head Neck Surg 1994 120 541–6.
   PubMed Web of Science ®Google Scholar
• British Society of Audiology. Recommended procedures for pure-tone audiometry using a manually operated instrument Br J Audiol 1981 15 213–6.
   PubMedGoogle Scholar
• British Society of Audiology. Recommended procedure for pure-tone bone-conduction audiometry without masking using a manually operated instrument Br J Audiol 1985 19 281–2.
   PubMedGoogle Scholar
• British Society of Audiology. Recommendations for masking in pure tone threshold audiometry Br J Audiol 1986 20 307–14.
   PubMedGoogle Scholar
• Brimmett, RE, Morrison, RB. The incidence of aminoglycoside antibiotic induced hearing loss Arch Otolaryngol Head Neck Surg 1990 116 406–410.
   PubMed Web of Science ®Google Scholar
• Chapman, P. Rapid onset hearing loss after cisplatin therapy: Case reports and a literature review J Laryngol Otol 1982 96 159–62.
   PubMed Web of Science ®Google Scholar
• Evans, WE, Yee, GC, Crom, WR, Pratt, CB, Green, AA. Clinical pharmacology of bleomycin and cisplatin Head and Neck Surg 1981 4 98–110.
   PubMedGoogle Scholar
• Fausti, SA, Schechter, MA, Rappaport, BZ, Frey, RH, Mass, RE. Early detection of cisplatin ototoxicity selected case reports Cancer 1984 53 224–31.
   PubMed Web of Science ®Google Scholar
• Fleischman, RW, Standnicki, SW, Ethieu, MF, Schaeppi, U. Ototoxicity of cis-dichlorodiamine platinum (II) in the guinea pig Toxicol Appl Pharmacol 1975 33 320–32.
   PubMed Web of Science ®Google Scholar
• Gratton, MA. The interaction of cisplatin and noise on the peripheral auditory system Hear Res 1990 50 211–24.
   PubMed Web of Science ®Google Scholar
• Hayes, DM, Cvitkovic, E, Golbey, RB, Scheiner, E, Helson, L, Krakoff, IH. High dose cis-platinum diammine dichloride: Amelioration of renal toxicity by mannitol diuresis Cancer 1977 39 1372–81.
   PubMed Web of Science ®Google Scholar
• Helson, L, Okonkwo, E, Anton, L, Cvitkovic, F. Cis-platinum ototoxicity Clin Toxicol 1978 13 469–78.
   PubMed Web of Science ®Google Scholar
• Johnsen, NJ, Elberling, C. Evoked acoustic emissions from the human ear. I Equipment and response parameters Scand Audiol 1982 11 3–12.
   PubMed Web of Science ®Google Scholar
• Kemp, DT. Stimulated acoustic emissions from within the human Auditory system J Acoust Soc Am 1978 64 1386–91.
   PubMed Web of Science ®Google Scholar
• Komune, S. Potentiating effects of cisplatin and ethacrynic acid in ototoxicity Arch Otolaryngol 1981 101 66–74.
   Google Scholar
• Lonsbury-Martin, BL, Martin, GK, McCoy, MJ, Whitehead, ML. New approaches to the evaluation of the auditory system and a current analysis of otoacoustic emissions Otolaryngol Head Neck Surg 1995 112 50–63.
   PubMed Web of Science ®Google Scholar
• McFadden, D, Plattsmier, HS, Pasanen, EG. Aspirin-induced hearing loss as a model of sensorineural hearing loss Hear Res 1984 16 251–60.
   PubMed Web of Science ®Google Scholar
• Meyerhoff, WL, Maale, GE, Yellin, W, Roland, PS. Audiologic threshold monitoring of patients receiving ototoxic drugs Ann Otol Rhinol Laryngol 1989 98 950–4.
   PubMed Web of Science ®Google Scholar
• Norton, SJ. Applications of transient evoked otoacoustic emissions to paediatric populations Ear Hear 1993 14 64–73.
   PubMed Web of Science ®Google Scholar
• Ozols, RF, Deisseroth, AB, Javadpour, N, Barlock, A, Messerschmidt, GL, Young, RG. Treatment of poor prognosis non-seminomatous testicular cancer with a ‘high-dose’ platinum combination chemotherapy regimen Cancer 1993 51 1803–7.
   Google Scholar
• Parti, R, Wolf, W. Quantitative subcellular distribution of platinum in renal tissues following IV bolus and IV infusion of cisplatin Chemother Pharmacol 1990 26 188–192.
   PubMed Web of Science ®Google Scholar
• Plinkert, PK, Krober, S. Fruherkennung einer Cisplatin-Ototoxizitat durch evozierte otoakustische Emissionen Laryngo-Rhino-Otologie 1991 70 457–62.
   PubMedGoogle Scholar
• Pollera, C. Very high dose cisplatin-induced ototoxicity: A preliminary report on early and long term effects Cancer Chemother Pharmacol 1988 21 61–4.
   PubMed Web of Science ®Google Scholar
• Rosenburg, B, Van Camp, L, Krigas, T. Inhibition of cell division in Ecoli by electrolysis produced from a platinum electrode Nature 1965 205 698–99.
   PubMed Web of Science ®Google Scholar
• Schaefer, SD, Wright, CG, Post, JD, Frenkel, EP. Cisplatinum vestibular toxicity Cancer 1981 47 857–9.
   PubMed Web of Science ®Google Scholar
• Schweitzer, V, Rarey, V, Dolon, D, Abrams, G, Litterst, C, Sheridan, C. Ototoxicity of cisplatin versus platinum analogues CBDCA (Jm-8) and CHIP (JM-9) Otolaryngology Head Neck Surg 1986 94 458–70.
   PubMed Web of Science ®Google Scholar
• Schweitzer, VG. Cisplatin-induced ototoxicity: Effect of pigmentation and inhibitory agents Laryngoscope 1993 (Suppl.) 59.
   Google Scholar
• Strauss, M, Towfighi, J, Lord, S, Lipton, A, Harvey, HA, Brown, B. Cisplatin ototoxicity: Clinical experience and temporal bone histopathology Laryngoscope 1983 93 1554–9.
   PubMed Web of Science ®Google Scholar
• Tange, RA, Dreschler, WA, Van Der Hulst, RJAM. The importance of high tone audiometry in monitoring for ototoxicity Arch Otorhinolaryngol 1985 242 77–81.
   PubMedGoogle Scholar
• Wake, M, Takeno, S, Ibrahim, D, Harrison, R, Mount, R. Carboplatin ototoxicity: An animal model J Laryngol Otol 1993 107 585–9.
   PubMed Web of Science ®Google Scholar
• Waters, GS, Ahmad, M, Katsarkas, A, Stanimir, G, McKay, J. Ototoxicity due to cis-diamminedi-chloroplatinum in the treatment of ovarian cancer: Influence of dosage and schedule of administration Ear Hear 1991 12 91–102.
   PubMed Web of Science ®Google Scholar
• Zorowka, PG. Otoacoustic emissions: A new method to diagnose hearing impairment in children Eur J Pediatr 1993 152 626–34.
   PubMed Web of Science ®Google Scholar
• Zorowka, PG, Schmitt, HJ, Gutjahr, P. Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatin therapy Int J Pediatr Otorhinolaryngol 1993 25 73–80.
   PubMed Web of Science ®Google Scholar